Data

New PROTECT III Data Demonstrates Impella® Reduces MACCE Compared to IABP

Top Downloads

Abiomed Cardiogenic Shock Protocol


Presentations

Jeffrey J. Popma, MD, Presents Data from PROTECT III Study

Watch this breakfast symposium presentation featuring data from the 2-year study of high-risk PCI patients supported with Impella and IABP

Protected PCI

SEE ALL

Cardiogenic Shock

SEE ALL

Newsletter

SUBSCRIBE

Upcoming Events


12.05.19
Complete Revascularization Summit: Optimizing Outcomes in Protected PCI | Phoenix 2019
Scottsdale, AZ
12.09.19
Spectrum Heart Team Implementation Course
Grand Rapids, MI
01.11.20
Orlando Surgical Skills Workshop
Orlando, FL
Data

New Data from NCSI Demonstrates 72% Survival with 98% Native Heart Recovery

The patients were treated with the NCSI protocol, which includes placing the Impella heart pump before revascularization

Training

Attend The Complete Revascularization Summit

Interventionalist seeking to better understand complex PCI in the modern era

Presentations

Largest FDA Study of High-Risk PCI Patients Shows Improved Outcomes with Impella® Heart Pumps

Jeffrey J. Popma, MD, presents the latest data from the PROTECT series clinical study

Multiple peer-reviewed publications demonstrate that #Impella use is associated with a reduction in length of stay for patients, with a greater opportunity for benefit as the illness level increases: bwnews.pr/2qnkDxn pic.twitter.com/cL8L6gLZzI

From Protected PCI's Twitter

November is Caregiver Appreciation Month. Learn how EMT Joella Bobak survived cardiogenic shock and eventually resumed her work of helping others: bit.ly/2Ng5msU pic.twitter.com/OK4VW4d2dA

From Abiomed's Twitter